Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Wegovy is also approved to lower cardiovascular risk in people with heart disease and who are either overweight or have obesity, however
GLP-1 medicationsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro)are administered subcutaneously, meaning they are injected into the fatty tissue just beneath the skin rather than into muscle
Some users also report increased urination, possibly related to improved glycemic control and reduced fluid retention
Many prescriptions such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and liraglutide (Victoza, Saxenda) are called GLP-1 receptor agonists (GLP-1s) because they mimic high levels of GLP-1
US$ 23.49
US$ 29.30
US$ 21.28
US$ 28.80
